Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions
January 18, 2024 | Advisory board, DOL, Digital opinion leader, KOL, KOL advisor, Key Opinion Leader, MSL, Online advisory board, Virtual advisory board, advisory board insights, pharma advisor, pharma insights
In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today’s diverse healthcare landscape.
7. Advisor Questions on Tailored Marketing
How can you tailor your marketing strategies to specific HCP groups, patient populations, countries, or regions? What key data or product attributes should you highlight to which population? What considerations should you keep in mind when marketing your product in certain regions?
Learn about other questions you should be asking your advisors, KOLs, DOLs, HCPs, MSLs, and internal stakeholders by reading our blog:
https://www.impetusdigital.com/2020/02/03/top-10-most-important-advisor-questions/
See more of our videos for more tips and insights how to customize your insight-gathering efforts to specific HCP groups, patient populations, and geographical regions.
For more information on how we can help you engage your advisors, HCPs, patients, and stakeholders, visit us at www.impetusdigital.com or talk to one of our amazing team members via https://meetwithimpetus.com/
Follow us on social media
https://linkedin.com/company/impetus-digital
https://twitter.com/impetus_digital
https://facebook.com/ImpetusDigital.fb
https://impetusdigital.com/podcast/
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Boosting Engagement with Fun: Asynchronous Touchpoints – Impetus InSite Tips for Optimizing Asynchronous Virtual Meetings
Unlock the secret to keeping participants engaged in longer asynchronous touchpoints with our sixth tip. Learn how integrating elements of fun can refresh focus and enhance interaction in virtual settings.
Navigating the rapidly changing oncology treatment landscape: how digital tools can help
With rapid growth comes growing pains...
Enhancing Focus in Virtual Meetings: Stick to a Theme – Impetus InSite Tips #5
Focus your virtual meetings with a clear theme! Tip 5 from our ImpetusInSite Tips series shows how sticking to one theme per touchpoint can dramatically improve engagement and coherence. Learn...
Effective Communication in Virtual Meetings: Stay Pithy – Impetus InSite Tips #4
Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today's fast-paced...
Enhancing Honesty in Feedback: Blinded Questions
Explore our third tip in our series aimed at refining asynchronous virtual meetings. Discover how using blinded questions can significantly minimize bias and enhance the integrity of feedback in virtual...
Streamlining Asynchronous Feedback: Scale Consistency – Impetus InSite Tips #2
Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable...
Clinical Trial Protocol Conceptualization: A Customer Story
To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical...
Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1
Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".
In-person, hybrid, or digital? State of Pharma meetings and events in 2024
We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.
Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions
This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...